Immuno Oncology Assays Market by Product (Software, Consumables), by Application (Clinical Diagnostics, Research), by Technology (Flow Cytometry, Immunoassay, Next Generation Sequencing, PCR), by Indication (Colorectal Cancer, Lung Cancer) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: April 1, 2020
Clear
SKU: GMS-1185 Category:

The immuno-oncology assay market size is projected to reach USD 5.83 billion by 2024, growing over the forecast period at a CAGR of 12.52%. This market’s growth is driven primarily by factors such as rising targeted therapy adoption over traditional therapy and increasing demand for Modeling and Analysis of Biological Systems.

Immuno Oncology Assays Market by Product (Software, Consumables), by Application (Clinical Diagnostics, Research), by Technology (Flow Cytometry, Immunoassay, Next Generation Sequencing, PCR), by Indication (Colorectal Cancer, Lung Cancer) - 2019 to 2024 1

Immuno Oncology Assays Market by Product (Software, Consumables), by Application (Clinical Diagnostics, Research), by Technology (Flow Cytometry, Immunoassay, Next Generation Sequencing, PCR), by Indication (Colorectal Cancer, Lung Cancer) - 2019 to 2024 2

Immuno Oncology Assays Market by Product (Software, Consumables), by Application (Clinical Diagnostics, Research), by Technology (Flow Cytometry, Immunoassay, Next Generation Sequencing, PCR), by Indication (Colorectal Cancer, Lung Cancer) - 2019 to 2024 3

Immuno Oncology Assays Market by Product (Software, Consumables), by Application (Clinical Diagnostics, Research), by Technology (Flow Cytometry, Immunoassay, Next Generation Sequencing, PCR), by Indication (Colorectal Cancer, Lung Cancer) - 2019 to 2024 4

Immuno Oncology Assays Market by Product (Software, Consumables), by Application (Clinical Diagnostics, Research), by Technology (Flow Cytometry, Immunoassay, Next Generation Sequencing, PCR), by Indication (Colorectal Cancer, Lung Cancer) - 2019 to 2024 5

Immuno Oncology Assays Market by Product (Software, Consumables), by Application (Clinical Diagnostics, Research), by Technology (Flow Cytometry, Immunoassay, Next Generation Sequencing, PCR), by Indication (Colorectal Cancer, Lung Cancer) - 2019 to 2024 6

Immuno Oncology Assays Market by Product (Software, Consumables), by Application (Clinical Diagnostics, Research), by Technology (Flow Cytometry, Immunoassay, Next Generation Sequencing, PCR), by Indication (Colorectal Cancer, Lung Cancer) - 2019 to 2024 7

Immuno Oncology Assays Market by Product (Software, Consumables), by Application (Clinical Diagnostics, Research), by Technology (Flow Cytometry, Immunoassay, Next Generation Sequencing, PCR), by Indication (Colorectal Cancer, Lung Cancer) - 2019 to 2024 8

1 Global Immuno Oncology Assays Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Immuno Oncology Assays Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Immuno Oncology Assays Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Immuno Oncology Assays Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Immuno Oncology Assays Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Immuno Oncology Assays Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Immuno Oncology Assays Market – By Product (Market Size – & million/billion)
8.1 Consumables
8.2 Software

9 Global Immuno Oncology Assays Market – By Technology
9.1 Immunoassay
9.2 PCR
9.3 NGS
9.4 Flow Cytometry
9.5 Other

10 Global Immuno Oncology Assays Market – By Indication
10.1 Lung Cancer
10.2 Colorectal Cancer
10.3 Melanoma
10.4 Other

11 Global Immuno Oncology Assays Market – By Application
11.1 Research Applications
11.2 Clinical Diagnostics

12 Global Immuno Oncology Assays Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Immuno Oncology Assays Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Immuno Oncology Assays Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Thermo Fisher Scientific, Inc.
14.3 Roche Diagnostics
14.4 Agilent Technologies, Inc.
14.5 Illumina, Inc.
14.6 HTG Molecular Diagnostics, Inc.
14.7 Nanostring Technologies, Inc.
14.8 Foundation Medicine
14.9 Sartorius AG
14.10 Qiagen
14.11 Merck
14.12 Company 11 & more

15 Global Immuno Oncology Assays Market – Appendix
15.1 Sources
15.2 Abbreviations